DSKYF:OTCMKTS
Daiichi Sankyo Co Ltd
17,63 USD
0,00%
(0,00) 1 D.
10-05, 13:19:10 GMT−4 · USD
search
Visi simboliai
| Simbolis | Kaina | Keisti | Pokytis, % |
|---|
insights_autoGeneruojamos svarbiausios „DSKYF“ įžvalgos...
Rinkos kapitalizacija
32,15 mlrd.
Vid. kiekis
2,70 tūkst.
Apimtis
25,00
52 sav. aukšta
29,15 USD
52 sav. žema
13,85 USD
Beta
−1,13
Neapmokėtos akcijos
1,86 mlrd.
Darbuotojų skaičius
20 tūkst.
Rinkos kapitalizacija
32,15 mlrd.
Vid. kiekis
2,70 tūkst.
Apimtis
25,00
52 sav. aukšta
29,15 USD
52 sav. žema
13,85 USD
Beta
−1,13
Neapmokėtos akcijos
1,86 mlrd.
Darbuotojų skaičius
20 tūkst.
Naujienų istorijos
Iš žiniatinklio šaltinių ir naujienų partnerių
AD HOC NEWS
·
prieš 1 dieną
Daiichi Sankyo expands Datroway trials: what it means for Daiichi Sankyo stock
Profilis
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent.
Daiichi Sankyo, Inc. began operating in the U.S. in 2006. It is the U.S. subsidiary of Daiichi Sankyo Company, Limited, and a member of the Daiichi Sankyo Group. The organization, which includes U.S. commercial operations and global clinical development, is headquartered in Basking Ridge, New Jersey.
Daiichi Sankyo Europe, GmbH, the European subsidiary, is headquartered in Munich, Germany. The organization is responsible for development and manufacturing for 12 European countries.
Daiichi Sankyo Company, Limited is a full member of the European Federation of Pharmaceutical Industries and Associations and of the International Federation of Pharmaceutical Manufacturers and Associations. Wikipedia
Apie „Daiichi Sankyo Co Ltd“
Generalinis direktoriusHiroyuki Okuzawa
Darbuotojai20,2 tūkst.
Įkurta2005-09-28
Pagrindinė būstinėČiūo, Tokijas, Japonija
Sektorius-
Svetainėdaiichisankyo.co.jp